0001596771-17-000041.txt : 20170531 0001596771-17-000041.hdr.sgml : 20170531 20170531162503 ACCESSION NUMBER: 0001596771-17-000041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170530 FILED AS OF DATE: 20170531 DATE AS OF CHANGE: 20170531 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gemphire Therapeutics Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 BUSINESS PHONE: 248-980-6538 MAIL ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gullans Steven R. Ph.D. CENTRAL INDEX KEY: 0001571997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 17881374 MAIL ADDRESS: STREET 1: C/O EXCEL VENTURE MANAGEMENT, LLC STREET 2: 800 BOYLSTON ST., STE 2825 CITY: BOSTON STATE: MA ZIP: 02199 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-05-30 0 0001638287 Gemphire Therapeutics Inc. GEMP 0001571997 Gullans Steven R. Ph.D. 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 1 1 0 0 Interim President & CEO Employee Stock Option (right to buy) 10.26 2017-05-30 4 A 0 60000 0 A 2027-05-29 Common Stock 60000 60000 D The option vests in 12 equal consecutive monthly increments, so that all of the shares will be vested on the one year anniversary of the date of grant, subject to acceleration upon the appointment of a permanent President and Chief Executive Officer. Stephanie Swan, by Power of Attorney 2017-05-31